Shorts
1:10
4 FDA-Approved Treatments for NMOSD You Should Know
3 months ago
by
Louie Pasculli
1:24
Clinical Value of EBNA1 Antibodies in MS, MOGAD, & NMOSD
3 months ago
by
Marco Meglio
1:01
Emerging CAR-T Therapy Approaches in NMOSD
3 months ago
by
Louie Pasculli
0:31
Addressing Access Barriers to Emerging Therapies in Neuromuscular Disease
3 months ago
by
Isabella Ciccone, MPH(+1 more)
1:33
Developing Pivotal Trials for Stem Cell-Based Agents in Multiple Sclerosis
3 months ago
by
Jeffrey Cohen, MD(+1 more)
0:48
MDA 2026: Accepting the MDA Legacy Award
3 months ago
by
Allison Moore(+1 more)
1:02
How Deramiocel Works
3 months ago
by
Noah Stansfield
0:51
Research and Collaboration in Neuromuscular Medicine
3 months ago
by
Marco Meglio(+1 more)
0:51
MDA 2026: Receiving the MDA Legacy Award
3 months ago
by
Michio Hirano, MD(+1 more)
0:51
MDA 2026: Future Vision of Neuromuscular Disorders
3 months ago
by
Isabella Ciccone, MPH(+1 more)
0:31
MDA 2026: Phase 2 ALKIVIA Study
3 months ago
by
Isabella Ciccone, MPH(+1 more)
0:47
MDA 2026: In the Shoes of the Patient
3 months ago
by
Isabella Ciccone, MPH(+1 more)
0:51
MDA 2026: The Future of Precision Medicine
3 months ago
by
Isabella Ciccone, MPH(+1 more)
1:33
Reasons Behind Eptinezumab's Effectiveness in Treatment-Resistant Migraine
3 months ago
by
Marco Meglio(+1 more)
0:56
Managing Neurologic Symptoms During Cancer Treatment
3 months ago
by
Ditte Primdahl, MD(+2 more)
0:49
Navigating Neurologic Complications During Cancer Therapy
3 months ago
by
Shailee Samir Shah, MD(+2 more)
1:32
Primary Care–Neurologist Collaboration After Stroke
3 months ago
by
Eva Mistry, MD (+1 more)
1:33
Assessing Potential of BD-Tau in Stroke-Related Brain Injury
3 months ago
by
Marco Meglio(+1 more)
0:55
Optimizing Immunotherapy in PNS During Cancer Care
3 months ago
by
Ditte Primdahl, MD(+2 more)
0:59
Managing Immunotherapy and Recovery in PNS
3 months ago
by
Shailee Samir Shah, MD(+2 more)
1:00
Differentiating PNS From Treatment-Related Neurotoxicity
3 months ago
by
Shailee Samir Shah, MD(+2 more)
1:01
Challenges in Diagnosing Paraneoplastic Neurologic Syndromes
3 months ago
by
Ditte Primdahl, MD(+2 more)
1:11
Differentiating Classic PNS from ICI-Related Toxicities
3 months ago
by
Ditte Primdahl, MD(+2 more)
0:27
Managing PNS in the Era of Immunotherapy
3 months ago
by
Shailee Samir Shah, MD(+2 more)
1:07
Prioritizing Malignancy Screening in Suspected PNS
3 months ago
by
Ditte Primdahl, MD(+2 more)
0:44
Screening Strategies for Suspected PNS
3 months ago
by
Shailee Samir Shah, MD(+2 more)
1:33
Phase 3b RESHAPE Trial Evaluates Switching From Ocrelizumab to Remibrutinib
3 months ago
by
Marisa McGinley, DO(+1 more)
0:50
Distinguishing PNS From Other Cancer-Associated Neurologic Complications
4 months ago
by
Ditte Primdahl, MD(+2 more)
1:19
Paraneoplastic Neurologic Syndromes at the Crossroads of Care
4 months ago
by
Shailee Samir Shah, MD(+2 more)
1:38
Interferon Signaling Pathways in the Brain Associated With MS Initiation
4 months ago
by
Louie Pasculli
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Earlier Pimavanserin Initiation May Alter Psychosis Symptom Trajectory in Parkinson's Disease, Exploratory Analysis Suggests
2
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
3
Real-World Survey Data Suggest Deutetrabenazine May Improve Quality of Life Measures in Huntington Disease Chorea
4
Subcutaneous Apomorphine Infusion Titration Reaches Optimization Without Antiemetics in Real-World PD Cohort
5